Importance of training in external beam treatment planning for locally advanced cervix cancer: Report from the EMBRACE II dummy run.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
04 2019
Historique:
received: 22 10 2018
revised: 27 12 2018
accepted: 09 01 2019
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 27 2 2020
Statut: ppublish

Résumé

The EMBRACE II study combines state-of-the-art Image-Guided Adaptive Brachytherapy in cervix cancer with an advanced protocol for external beam radiotherapy (EBRT) which specifies target volume selection, contouring and treatment planning. In EMBRACE II, well-defined EBRT is an integral part of the overall treatment strategy with the primary aim of improving nodal control and reducing morbidity. The EMBRACE II EBRT planning concept is based on improved conformality through relaxed coverage criteria for all target volumes. For boosting of lymph nodes, a simultaneous integrated boost and coverage probability planning is applied. Before entering EMBRACE II, institutes had to go through accreditation. As part of accreditation, a treatment planning dummy-run included educational blocks and submission of an examination case provided by the study coordinators. Seventy-one centers submitted 123 EBRT dose distributions. Replanning was required if hard constraints were violated or planning concepts were not fully accomplished. Dosimetric parameters of original and revised plans were compared. Only 11 plans violated hard constraints. Twenty-seven centers passed after first submission. 27 needed one and 13 centers needed more revisions. The most common reasons for revisions were low conformality, relatively high OAR doses or insufficient lymph node coverage reduction. Individual feedback on planning concepts improved plan quality considerably, resulting in a median body V43Gy reduction of 158 cm A dummy-run as applied in EMBRACE II, consisting of training and examination cases enabled us to test institutes' treatment planning capabilities, and improve plan quality.

Sections du résumé

BACKGROUND AND PURPOSE
The EMBRACE II study combines state-of-the-art Image-Guided Adaptive Brachytherapy in cervix cancer with an advanced protocol for external beam radiotherapy (EBRT) which specifies target volume selection, contouring and treatment planning. In EMBRACE II, well-defined EBRT is an integral part of the overall treatment strategy with the primary aim of improving nodal control and reducing morbidity. The EMBRACE II EBRT planning concept is based on improved conformality through relaxed coverage criteria for all target volumes. For boosting of lymph nodes, a simultaneous integrated boost and coverage probability planning is applied. Before entering EMBRACE II, institutes had to go through accreditation.
MATERIAL AND METHODS
As part of accreditation, a treatment planning dummy-run included educational blocks and submission of an examination case provided by the study coordinators. Seventy-one centers submitted 123 EBRT dose distributions. Replanning was required if hard constraints were violated or planning concepts were not fully accomplished. Dosimetric parameters of original and revised plans were compared.
RESULTS
Only 11 plans violated hard constraints. Twenty-seven centers passed after first submission. 27 needed one and 13 centers needed more revisions. The most common reasons for revisions were low conformality, relatively high OAR doses or insufficient lymph node coverage reduction. Individual feedback on planning concepts improved plan quality considerably, resulting in a median body V43Gy reduction of 158 cm
CONCLUSION
A dummy-run as applied in EMBRACE II, consisting of training and examination cases enabled us to test institutes' treatment planning capabilities, and improve plan quality.

Identifiants

pubmed: 30935571
pii: S0167-8140(19)30017-9
doi: 10.1016/j.radonc.2019.01.012
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-155

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Yvette Seppenwoolde (Y)

Department of Radiation Oncology, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria. Electronic address: Yvette.Seppenwoolde@meduniwien.ac.at.

Marianne Sanggaard Assenholt (MS)

Department of Oncology, Aarhus University Hospital, Denmark.

Dietmar Georg (D)

Department of Radiation Oncology, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria.

Remi Nout (R)

Department of Clinical Oncology, Leiden University Medical Centre, The Netherlands.

Li Tee Tan (LT)

Cambridge University Addenbrooke's Hospital, Department of Radiotherapy, United Kingdom.

Tamara Rumpold (T)

Department of Radiation Oncology, Comprehensive Cancer Center Medical University of Vienna, Austria.

Astrid de Leeuw (A)

Department of Radiotherapy, University Medical Center Utrecht, The Netherlands.

Ina Jürgenliemk-Schulz (I)

Department of Radiotherapy, University Medical Center Utrecht, The Netherlands.

Christian Kirisits (C)

Department of Radiation Oncology, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria.

Richard Pötter (R)

Department of Radiation Oncology, Comprehensive Cancer Center Medical University of Vienna, Austria.

Jacob Christian Lindegaard (JC)

Department of Oncology, Aarhus University Hospital, Denmark.

Kari Tanderup (K)

Department of Oncology, Aarhus University Hospital, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH